Speaker Profile
Ph.D., Director, Population Health, Olink
Biography
Cindy is passionate about innovation to make genetic and multi omic technologies easier and cheaper to measure. She sees such innovation as pivotal to lower the barrier of entry for implementing scalable, reproducible solutions advancing individualized medicine and healthequity.In over 14 years at Illumina and together with customers, shehelpeddevelop solutions to advance the understanding of genetic risk andholdsseveral USDA Excellence in Technology Transfer awards for her workleadingIlluminas Consortia Program. She joined Olink in 2020 soon afterthe launchof the Explore Platform that leverages next generationsequencing as a highthroughput proteomic readout. Ask her about how highthroughput proteomicsare helping translate the impact our genetics has onmore real timehealth.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
